EBIT: Income before interest and taxes.
Galera Therapeutics, Inc. (GRTX) had EBIT of $-2.54M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$149.05M |
|
-- |
|
-- |
|
$2.54M |
|
$-2.54M |
|
$151.59M |
|
$149.05M |
|
$149.05M |
|
$149.05M |
|
$149.05M |
|
$149.05M |
|
$149.05M |
|
|
EBIT |
$-2.54M |
$-2.54M |
|
98.50M |
|
98.50M |
|
$0.64 |
|
$0.64 |
|
| Balance Sheet Financials | |
$7.09M |
|
-- |
|
$0.10M |
|
$7.20M |
|
$0.65M |
|
-- |
|
$2.58M |
|
$3.22M |
|
$3.97M |
|
$3.97M |
|
$3.97M |
|
75.46M |
|
| Cash Flow Statement Financials | |
$-6.05M |
|
$3.50M |
|
$0.64M |
|
$8.29M |
|
$6.38M |
|
$-1.91M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
3750.58% |
|
3750.60% |
|
2071.28% |
|
3750.60% |
|
$0.05 |
|
$-0.06 |
|
$-0.06 |
|